Cullinan Therapeutics, Inc. · NASDAQ:CGEM
State Street Corp reported a 6.00% stake in Cullinan Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 6.00% stake in Cullinan Therapeutics, Inc., 3,668,627 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 3,668,627
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 6.00% | 3,668,627 |
Source
Related
- Cullinan Therapeutics, Inc.
- State Street Corp
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Form 4 · Michaelson Jennifer · Jul 7, 2026